Drug price bill pruned in Senate in partial industry win

Bloomberg

6 August 2022 - Medicare to be allowed to negotiate drug prices for first time.

Medicare was cleared to negotiate drug prices by the Senate's top official rules official, though the Democrat's proposal intended to cap price increases for prescription drugs in the commercial market was blocked.

Read Bloomberg article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing